Oncocytic papillary renal cell carcinoma (PRCC) is a distinct subtype of PRCC, listed as a possible new variant of PRCC in the 2016 WHO classification. It is composed of papillae aligned by large single-layered eosinophilic cells showing linearly arranged oncocytoma-like nuclei. We analyzed clinicopathologic, morphologic, immunohistochemical and molecular-genetic characteristics of 11 oncocytic PRCCs with prominent tumor lymphocytic infiltrate, morphologically resembling Warthin's tumor. The patients were predominantly males (8/11, 73%), with an average age of 59years (range 14-76), and a mean tumor size of 7cm (range 1-22cm). Tumors had the features of oncocytic PRCCs with focal pseudostratification in 8/11 cases and showed dense stromal inflammatory infiltration in all cases. Papillary growth pattern was predominant, comprising more than 60% of tumor volume. Tubular and solid components were present in 5 and 3 cases, respectively. Uniform immunohistochemical positivity was found for AMACR, PAX-8, MIA, vimentin, and OSCAR. Tumors were mostly negative for carboanhydrase 9, CD117, CK20, and TTF-1. Immunohistochemical stains for DNA mismatch repair proteins MLH1 and PMS2 were retained in all cases, while MSH2 and MSH6 were negative in 1 case. Tumor infiltrating lymphocytes (TILs) consisted of both B and T cells. Chromosomal copy number variation analysis showed great variability in 5 cases, ranging from a loss of one single chromosome to complex genome rearrangements. Only one case showed gains of chromosomes 7 and 17, among other aberrations. In 4 cases no numerical imbalance was found. Follow up data was available for 9 patients (median 47.6months, range 1-132). In 6 patients no lethal progression was noted, while 3 died of disease. In conclusion, Warthin-like PRCC is morphologically very close to oncocytic PRCC, from which it differs by the presence of dense lymphoid stroma. Chromosomal numerical aberration pattern of these tumors is variable; only one case showed gains of chromosomes 7 and 17. Warthin-like PRCC is a potentially aggressive tumor since a lethal outcome was recorded in 3/9 cases.

Biopticka Laboratory Pilsen Czech Republic

Department of Pathology Bellvitge University Hospital Barcelona Spain

Department of Pathology Centro Medico Mexico City Mexico

Department of Pathology Charles University Medical Faculty and Charles University Hospital Plzen Czech Republic

Department of Pathology Instituto Nacional de Cancerologia Mexico City Mexico

Department of Pathology Masaryk's Oncologic Institute University Hospital Brno Czech Republic

Department of Pathology University of British Columbia Royal Columbian Hospital Vancouver BC Canada

Department of Pathology University of Sarajevo Clinical Center Sarajevo Bosnia and Herzegovina

Department of Radiation Oncology Oncology Institute Kosice Slovakia

Department of Urology Charles University Medical Faculty and Charles University Hospital Plzen Czech Republic

Department Pathology Regional Hospital Jindrichuv Hradec Czech Republic

Department Pathology Regional Hospital Most Czech Republic

Ljudevit Jurak Pathology Department Clinical Hospital Center Sestre milosrdnice Zagreb Croatia

Citace poskytuje Crossref.org

New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia

Molecular Genetics of Renal Cell Tumors: A Practical Diagnostic Approach